Nitric oxide (NO) produced by the endothelium diffuses both into the lumen and to the smooth muscle cells according to the concentration gradient in each direction. The extremely high reaction rate between NO and hemoglobin (Hb), k Hb ؍ 3-5 ؋ 10 7 M ؊1 ⅐s ؊1 , suggests that most of the NO produced would be consumed by Hb in the red blood cells (RBCs), which then would block the biological effect of NO. Therefore, specific mechanisms must exist under physiological conditions to reduce the NO consumption by RBCs, in which the Hb concentration is very high (24 mM heme). By using isolated microvessels as a bioassay, here we show that physiological concentrations of RBCs in the presence of intravascular f low does not inhibit NO-mediated vessel dilation, suggesting that RBCs under this condition are not an NO scavenger. On the other hand, RBCs (50% hematocrit) without intravascular f low reduce NO-mediated dilation to serotonin by 30%. In contrast, free Hb (10 M) completely inhibits NO-mediated dilation with or without intravascular f low. The effect of f low on NO consumption by RBCs may be attributed to the formation of an RBC-free zone near the vessel wall, which is caused by hydrodynamic forces on particles. Intravascular f low does not affect the reaction rate between NO and free Hb in the lumen, because the latter forms a homogeneous solution and is not subject to the hydrodynamic separation. However, intravascular f low only partially contributes to the reduced consumption of NO by RBCs, because without the f low, the NO consumption by RBCs is already about 3 orders of magnitude slower than free Hb.Nitric oxide (NO) is a biological messenger that participates in neurotransmission, vascular regulation, and immunological responses. It is produced in many cell types such as neurons, endothelial cells vascular smooth muscle cells, and macrophages. Since the discovery of its biological activity, the roles of NO in physiological and pathophysiological processes have been seen as increasingly important. In the cardiovascular system, NO has been documented to participate in the regulation of vascular tone and permeability (1, 2), platelet adhesion and aggregation (3, 4), smooth muscle proliferation (5, 6), and endothelial cell-leukocyte interactions (1, 7). The functions of NO in vivo have been clearly demonstrated by administration of L-arginine analogs that block NO production. For example, the administration of N G -monomethyl-L-arginine (L-NMMA) has been shown to cause hypertension in vivo (8) and abolish shear-induced, NO-mediated vessel dilation both in vivo (9) and in isolated intact vessel preparation (10).Despite the well-documented importance of NO, the transfer of NO from the producing cell to the target is poorly understood, because NO, as a free radical, can be degraded in a variety of reactions. In particular, NO reacts with deoxy-and oxy-hemoglobin (Hb) at a very high rate to form nitrosyl-Hb (HbNO), and metHb, respectively. The bimolecular reaction rate constants for these reactions are on th...